At the Children with Diabetes convention at DisneyWorld in July Dr. Irl Hirsch announced that a new Accu-Chek device is the first good way that we have to measure glycemic variability, because it incorporates new low and high blood glucose indices. It’s a big step forward, but the product’s developer tells me that what it offers is something else.
While I am vacationing in New Mexico, I combined a little business with pleasure by visiting VeraLight Inc. in Albuquerque on Friday. I wanted to check out their device that uses fluorescence to non-invasively measure advanced glycation end-products (AGEs) in the skin.
The brand new dHealth Network really does make health management easy, as it claims. I know because I have been helping them to test it for the past two months.